NanoViricides Statistics

Total Valuation

NanoViricides has a market cap or net worth of $22.84 million. The enterprise value is $20.29 million.

Market Cap	22.84M
Enterprise Value	20.29M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

NanoViricides has 15.64 million shares outstanding. The number of shares has increased by 20.50% in one year.

Current Share Class	15.64M
Shares Outstanding	15.64M
Shares Change (YoY)	+20.50%
Shares Change (QoQ)	+9.98%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	9.51%
Float	15.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.57
P/TBV Ratio	2.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.27

Current Ratio	2.27
Quick Ratio	2.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-66,224.18

Financial Efficiency

Return on equity (ROE) is -99.84% and return on invested capital (ROIC) is -63.30%.

Return on Equity (ROE)	-99.84%
Return on Assets (ROA)	-57.38%
Return on Invested Capital (ROIC)	-63.30%
Return on Capital Employed (ROCE)	-111.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.47% in the last 52 weeks. The beta is 0.95, so NanoViricides's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-29.47%
50-Day Moving Average	1.26
200-Day Moving Average	1.43
Relative Strength Index (RSI)	61.60
Average Volume (20 Days)	102,164

Short Selling Information

The latest short interest is 130,447, so 0.83% of the outstanding shares have been sold short.

Short Interest	130,447
Short Previous Month	145,450
Short % of Shares Out	0.83%
Short % of Float	0.87%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.87M
Pretax Income	n/a
Net Income	-9.73M
EBITDA	-9.09M
EBIT	-9.87M
Earnings Per Share (EPS)	-$0.69

Full Income Statement

Balance Sheet

The company has $2.54 million in cash and n/a in debt, giving a net cash position of $2.54 million or $0.16 per share.

Cash & Cash Equivalents	2.54M
Total Debt	n/a
Net Cash	2.54M
Net Cash Per Share	$0.16
Equity (Book Value)	8.83M
Book Value Per Share	0.55
Working Capital	1.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$144,927, giving a free cash flow of -$8.40 million.

Operating Cash Flow	-8.26M
Capital Expenditures	-144,927
Free Cash Flow	-8.40M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NanoViricides does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.50%
Shareholder Yield	-20.50%
Earnings Yield	-42.59%
FCF Yield	-36.80%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 24, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Sep 24, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1